Stockscreener 앱 받기
9.55
0.31%
-0.03
전일 마감가:
$9.58
열려 있는:
$9.63
하루 거래량:
893.21K
Relative Volume:
0.80
시가총액:
$578.64M
수익:
$217.11M
순이익/손실:
$-651.19M
주가수익비율:
-0.7352
EPS:
-12.99
순현금흐름:
$-387.26M
1주 성능:
+3.35%
1개월 성능:
+15.62%
6개월 성능:
-0.52%
1년 성능:
-6.37%
1일 변동 폭
$9.547
$10.42
1주일 범위
$9.06
$10.42
52주 변동 폭
$5.00
$17.58
깅코 바이오웍스 홀딩스 Stock (DNA) Company Profile
명칭
Ginkgo Bioworks Holdings Inc
전화
(877) 442-5362
주소
27 DRYDOCK AVENUE, BOSTON
DNA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DNA
Ginkgo Bioworks Holdings Inc
|
9.55 | 580.45M | 217.11M | -651.19M | -387.26M | -12.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
깅코 바이오웍스 홀딩스 Stock (DNA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-05-15 | 다운그레이드 | BTIG Research | Neutral → Sell |
| 2024-05-10 | 다운그레이드 | William Blair | Mkt Perform → Underperform |
| 2023-11-14 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-11-09 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-06-02 | 다운그레이드 | Goldman | Neutral → Sell |
| 2023-05-11 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2022-11-29 | 개시 | Berenberg | Buy |
| 2022-10-04 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-05-18 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-03-02 | 재개 | Cowen | Outperform |
| 2022-02-23 | 개시 | Goldman | Neutral |
| 2022-02-01 | 개시 | BofA Securities | Neutral |
| 2022-01-28 | 개시 | BofA Securities | Buy |
| 2022-01-07 | 개시 | BTIG Research | Buy |
| 2021-11-29 | 개시 | Jefferies | Buy |
| 2021-10-13 | 개시 | Raymond James | Outperform |
| 2021-10-12 | 개시 | William Blair | Outperform |
| 2021-09-20 | 개시 | HSBC Securities | Buy |
모두보기
깅코 바이오웍스 홀딩스 주식(DNA)의 최신 뉴스
Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY: DNA - FinancialContent
Discipline and Rules-Based Execution in DNA Response - Stock Traders Daily
Ginkgo Bioworks Holdings, Inc. (DNA) Increases Despite Market Slip: Here's What You Need to Know - sharewise.com
Aug Sentiment: Why is Ginkgo Bioworks Holdings Inc stock going upMarket Growth Review & Target Return Focused Picks - baoquankhu1.vn
Twist Bioscience and Ginkgo Bioworks update 2022 partnership - MSN
Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference - Chartmill
Exit Recap: Will Ginkgo Bioworks Holdings Inc. stock recover faster than marketWeekly Trading Summary & Fast Gain Swing Alerts - Bộ Nội Vụ
Why The Narrative Around Ginkgo Bioworks Holdings (DNA) Is Shifting After New Fair Value Reset - Yahoo Finance
Why hedge funds are buying Ginkgo Bioworks Holdings Inc. stock2025 Investor Takeaways & Technical Pattern Alert System - Улправда
Ginkgo Bioworks Holdings, Inc. (DNA) rises as market takes a dip: Key facts - MSN
Can Ginkgo Bioworks Holdings Inc. stock beat analyst upgradesPortfolio Gains Report & Growth Focused Entry Point Reports - Улправда
Is Ginkgo Bioworks Holdings Inc. stock overvalued by current metricsQuarterly Growth Report & Community Trade Idea Sharing - Улправда
Ginkgo Bioworks Holdings, Inc. (DNA) stock dips while market gains: Key facts - MSN
Can Ginkgo Bioworks Holdings Inc. Class stock surprise markets with earnings2025 Analyst Calls & Growth Focused Stock Pick Reports - Улправда
How rising interest rates impact Ginkgo Bioworks Holdings Inc. stock2025 Macro Impact & AI Enhanced Market Trend Forecasts - Улправда
Bull Bear: How Ginkgo Bioworks Holdings Inc. stock trades before earningsEarnings Trend Report & Weekly High Potential Alerts - Улправда
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts - sharewise.com
Can Ginkgo Bioworks Holdings Inc. stock rebound after recent weakness2025 Market Overview & Long-Term Investment Growth Plans - Улправда
Aug Gainers: Can Ginkgo Bioworks Holdings Inc. stock rebound after recent weaknessInflation Watch & Safe Entry Momentum Tips - Улправда
TD Cowen Lowers Ginkgo Bioworks (NYSE:DNA) Price Target to $12.00 - MarketBeat
How Ginkgo Bioworks Holdings Inc. Class stock reacts to Fed tighteningEarnings Performance Report & Fast Exit Strategy with Risk Control - Улправда
Analyst Downgrade: Can Ginkgo Bioworks Holdings Inc. stock rebound after recent weaknessTrend Reversal & Trade Opportunity Analysis Reports - ulpravda.ru
Ginkgo Bioworks realigns leadership, shifts COO responsibilities - MSN
Ginkgo Bioworks (DNA) Upgraded to Strong Buy: Here's What You Should Know - MSN
Ginkgo Bioworks announces COO transition and operational leadership changes By Investing.com - Investing.com Australia
Ginkgo Bioworks announces COO transition and operational leadership changes - Investing.com
Is Ginkgo Bioworks Holdings Inc a good long term investmentInsider Trading Compliance & Affordable Trading Techniques - earlytimes.in
Penny Stocks That Will Make You Richcareer Html Definition Characteristics & How To Invest - shababeek.org
Ginkgo Bioworks Holdings, Inc. (DNA) Rises As Market Takes a Dip: Key Facts - sharewise.com
Ginkgo Bioworks Holdings Insider Sellers Miss The Bus As Stock Jumps 10.0% - simplywall.st
Liquidity Mapping Around (DNA) Price Events - Stock Traders Daily
Ginkgo Bioworks announces operating leadership transition effective January 2026 By Investing.com - Investing.com India
Ginkgo Bioworks announces operating leadership transition effective January 2026 - Investing.com
Ginkgo Bioworks Announces COO Transition - TradingView — Track All Markets
Ginkgo Bioworks shifts operating duties in leadership restructure - StreetInsider
Ginkgo Bioworks (NYSE: DNA) realigns leadership as Shetty refocuses on lab - Stock Titan
Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach - Sahm
Ginkgo Bioworks (DNA) Shares Rise On New Cancer Screening Approach Plans - Sahm
Ginkgo Bioworks, Carnegie Mellon Partner on At-Home Cancer Detection Technology - marketscreener.com
Ginkgo Bioworks Partners with CMU to Develop Innovative Cancer Detection Technology - Intellectia AI
Ginkgo Bioworks partners with CMU on innovative cancer detection By Investing.com - Investing.com Canada
Ginkgo Bioworks (NYSE:DNA) Trading Up 10%Time to Buy? - MarketBeat
Will Ginkgo Bioworks Holdings Inc. stock recover faster than marketJuly 2025 Price Swings & Low Drawdown Trading Strategies - Улправда
Is Ginkgo Bioworks Holdings Inc. stock resilient to inflationEarnings Miss & Consistent Income Trade Ideas - DonanımHaber
Is Ginkgo Bioworks Holdings Inc. stock a contrarian buy2025 Price Momentum & Weekly Top Performers Watchlists - Улправда
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: A 29.45% Upside Amidst Biotech Challenges - DirectorsTalk Interviews
깅코 바이오웍스 홀딩스 (DNA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):